Journal: In Vivo
Article Title: Renal Expression Levels of C5a Receptor and Autophagy‐related Beclin‐1 and LC3A/B Are Simultaneously Enhanced Under Immunoglobulin Treatment in a Rat Model of Sepsis
doi: 10.21873/invivo.13883
Figure Lengend Snippet: Kidney expression levels of C5a receptor (C5aR), LC3A/B and beclin-1 evaluated using immunoblotting, quantified by measuring band intensity, normalized by β-actin expression, and expressed as arbitrary units in control, sham, cecal ligation perforation (CLP)+saline, CLP+IgG and CLP+IgGAM treatment arms. Vertical bars indicate standard deviations. Symbols above the vertical bars denote significant differences between the IgG and IgGAM treatment groups vs. control (*), sham (#) and CLP+saline (†) groups. Significant differences between CLP+IgG and CLP+IgGAM groups are denoted by § at the 1 st (24 h) (1d, green) and 10 th (10d, blue) days of the experiment. *,#,†,§ p<0.05; **,##,††,§§ p<0.01; ***,###,††† p<0.001.
Article Snippet: Then, anti-rat C5aR (Thermo Fisher Scientific), Beclin-1 (Cell Signaling, Danvers, MA, USA) and LC3A/B (Cell Signaling) primary antibodies were applied in 2.5% skim milk and the membrane was incubated at +4˚C overnight. β-actin (Abcam) was used as the reference protein.
Techniques: Expressing, Western Blot, Control, Ligation, Saline